Manipal Hospitals
| Índia | Turquia | Áustria | |
| Terapia com Actínio-225 | de $8,500 | de $22,955 | de $55,000 |
| NanoKnife | de $8,500 | de $9,500 | de $25,000 |
| CyberKnife | de $6,000 | de $4,750 | de $50,000 |
| Enucleação de tumor no pâncreas | de $5,500 | de $10,000 | - |
A Bookimed não adiciona taxas extras aos preços de tratamento de Tumores neuroendócrinos pancreáticos. As tarifas vêm das listas oficiais de preços das clínicas. O pagamento é feito diretamente na clínica na chegada ao país.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais no tratamento de Tumores neuroendócrinos pancreáticos e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de tratamento de Tumores neuroendócrinos pancreáticos.
O Dr. Chaitainya Borde realizou mais de 30.000 exames de PET e tratou mais de 1.000 pacientes com cancro da tiroide no HCG Manavata Cancer Centre.
O Dr. Sridhar é especializado em radioterapia para tumores neuroendócrinos pancreáticos no HCG Manavata Cancer Centre, com vasta formação em radioncologia.
A Dra. Shruti Kate é especialista em tumores neuroendócrinos pancreáticos, formada no Tata Memorial Hospital – um dos principais centros de oncologia da Índia.
Pancreatic neuroendocrine tumors (pNETs) originate in hormone-producing cells, whereas standard pancreatic cancer arises from enzyme-producing cells. pNETs usually grow slower and offer better survival rates. Indian hospitals utilize specialized tools like Ga-68 DOTATATE PET-CT scans and Lu-177 PRRT to target these specific islet cell tumors.
Bookimed Expert Insight: While standard pancreatic cancer requires immediate aggressive surgery, pNET treatment in India focuses on tumor biology. Data shows that specialized centers like HCG Manavata utilize NanoKnife technology, costing around $8,500 to $14,500, for tumors near sensitive vessels where traditional surgery might be too risky. This tech-driven precision allows for treating complex cases that other regions might consider inoperable.
Patient Consensus: Patients emphasize that pNETs are unique and require checking specific details like the Ki-67 index and grade before starting treatment. They often note that a generic cancer diagnosis can change after a specialized pathology review at large Indian tertiary centers.
Indian hospitals offer surgical options for pancreatic neuroendocrine tumors (pNETs) ranging from organ-sparing enucleation to radical resections. Specialists use robotic systems and laparoscopic techniques to preserve pancreatic function. Choice depends on tumor size, type, and location within the organ.
Bookimed Expert Insight: While many hospitals focus on traditional surgery, Dr. Rela Institute & Medical Centre utilizes the Da Vinci robotic system for high-precision pancreatic resections. This technology is particularly effective for organ-sparing procedures like enucleation. Packages for enucleation in India range from $5,500 to $10,500. This is approximately 70% lower than costs in Western Europe or the US for the same robotic approach.
India uses advanced non-surgical treatments for metastatic pancreatic neuroendocrine tumors (pNETs) like Peptide Receptor Radionuclide Therapy (PRRT). Experts apply 177Lu-DOTATATE and 225Ac-DOTATOC to target cancer cells. Facilities also offer CyberKnife radiosurgery and Targeted Alpha Therapy to treat complex cases without invasive surgery.
Bookimed Expert Insight: Indian oncology centers like HCG Manavata provide a unique concentration of expertise in both nuclear medicine and clinical research. Our data shows specialists like Dr. Raj Nagarkar have participated in over 200 clinical trials. This research focus means patients often access the latest dosing protocols for targeted therapies like immunotherapy and metronomic therapy sooner than at general hospitals.
Five-year survival rates for pancreatic neuroendocrine tumors (pNETs) in India range from 40% to 60% overall. Localized tumors show excellent outcomes with 83% to 90% survival. Advanced multidisciplinary centers like Manipal Hospitals and HCG Manavata provide specialized surgical and nuclear medicine interventions.
Bookimed Expert Insight: Patient volume serves as a critical quality indicator for complex pNET care. Manipal Hospitals treats 2,000,000 patients annually across 15 facilities. High-volume centers often demonstrate better surgical outcomes. Dr. Chaitainya Borde at HCG Manavata has managed 30,000+ PET scans. This volume suggests high diagnostic accuracy for staging.
Patient Consensus: Patients emphasize that long-term survival requires ongoing monitoring even after surgery. Success is often viewed as maintaining a good quality of life while managing the tumor as a chronic condition.
Top Indian hospitals for pancreatic neuroendocrine tumors (pNETs) include Manipal Hospitals, Dr. Rela Institute, and HCG Manavata Cancer Centre. These centers provide infrastructure like Ga-68 DOTATATE PET-CT scans for precise tumor mapping. Specialized nuclear medicine departments offer Lu-177 and Actinium-225 therapies for advanced cases.
Bookimed Expert Insight: While many seek care in New Delhi or Mumbai, Nashik has emerged as a specialized hub with HCG Manavata Cancer Centre. This facility has managed over 30,000 PET scans and provides rare Actinium-225 therapy. Dr. Chaitainya Borde at this center has treated 1,000+ patients, offering high-volume expertise outside the major metro capitals.
Patient Consensus: Patients emphasize finding a dedicated pancreatic surgeon rather than a general oncologist. They also stress that confirming your Ki-67 grading and proper tumor classification is vital before starting any treatment.